Free Trial
Stephanie Davis

Stephanie Davis Analyst Performance

Non Agency CMBS Trading Analyst at Barclays

Stephanie Davis is a stock analyst at Barclays across a range of sectors, covering 34 publicly traded companies. Over the past year, Stephanie Davis has issued 2 stock ratings, including and buy recommendations. While full access to Stephanie Davis' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Stephanie Davis' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
122 Last 12 Years
Buy Recommendations
51.24% 62 Buy Ratings
Companies Covered
34 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy51.2%61 ratings
Hold47.9%58 ratings
Sell0.8%1 ratings

Out of 121 total stock ratings issued by Stephanie Davis at Barclays, the majority (51.2%) have been Buy recommendations, followed by 47.9% Hold and 0.8% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
73.5% of companies on NYSE
25 companies
NASDAQ
23.5% of companies on NASDAQ
8 companies
OTCMKTS
2.9% of companies on OTCMKTS
1 company

Stephanie Davis, an analyst at Barclays, currently covers 34 companies listed on NYSE, NASDAQ and OTCMKTS, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Industrials
19 companies
55.9%
Healthcare
13 companies
38.2%
Miscellaneous
1 company
2.9%
Consumer Discretionary
1 company
2.9%

Stephanie Davis of Barclays specializes in stock coverage within the Industrials sector, with additional focus on Healthcare and companies.

Coverage Industries

IndustryPercentage
HEALTHCARE TECHNOLOGY
8 companies
23.5%
MACHINERY
7 companies
20.6%
HEALTHCARE PROVIDERS & SERVICES
3 companies
8.8%
ELECTRICAL EQUIPMENT
3 companies
8.8%
TRADING COMPANIES & DISTRIBUTORS
3 companies
8.8%
INDUSTRIAL CONGLOMERATES
2 companies
5.9%
BUILDING PRODUCTS
2 companies
5.9%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
2.9%
Miscellaneous
1 company
2.9%
LIFE SCIENCES TOOLS & SERVICES
1 company
2.9%
DIVERSIFIED CONSUMER SERVICES
1 company
2.9%
AEROSPACE & DEFENSE
1 company
2.9%
PROFESSIONAL SERVICES
1 company
2.9%

Stephanie Davis' Ratings History at Barclays

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2/11/2026Boost Price Target$204.01$225.00Overweight
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
1/30/2026Upgrade$182.31$210.00Overweight
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
10/22/2025Boost Price Target$181.81$195.00Equal Weight
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
10/2/2025Boost Price Target$182.04$190.00Equal Weight
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4/23/2025Boost Price Target$172.56$185.00Equal Weight
Waystar Holding Corp. stock logo
WAY
Waystar
4/14/2025Lower Price Target$36.58$45.00Overweight
Waystar Holding Corp. stock logo
WAY
Waystar
2/19/2025Boost Price Target$45.11$50.00Overweight
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
1/31/2025Boost Price Target$163.97$175.00Equal Weight